Breaking News Instant updates and real-time market news.

AKRX

Akorn

$31.30

-0.03 (-0.10%)

, FSNUY

Fresenius SE

$19.91

0.505 (2.60%)

13:21
02/15/18
02/15
13:21
02/15/18
13:21

MLex says Akorn/Fresenius unlikely to be halted by FTC issues, Bloomberg reports

AKRX

Akorn

$31.30

-0.03 (-0.10%)

FSNUY

Fresenius SE

$19.91

0.505 (2.60%)

AKRX Akorn
$31.30

-0.03 (-0.10%)

08/22/17
GABE
08/22/17
NO CHANGE
GABE
Akorn deal still likely to close, says Gabelli
Gabelli says that Akorn's (AKRX) stock fell below $32 last week on worries that Fresenius (FMS) could restructure or break its deal to acquire the company. However, the firm still expects the deal to close, by early next year, as it does not believe that Fresenius' "disappointing" Q2 results or subpoenas related to the pricing of individual drugs would trigger the deal's material adverse event clause. Gabelli keeps a Hold rating on Akorn.
08/29/17
PIPR
08/29/17
NO CHANGE
Target $34
PIPR
Neutral
Piper still sees high likelihood of Akorn deal closing
Piper Jaffray analyst David Amsellem says that while wondering if Fresenius could back out of its planned purchase of Akorn (AKRX) is a fair question given the pressures on the broader generic space, he believes the likelihood of the transaction closing is still high. With that said, Amsellem notes that his analysis suggests a fair valuation for Akorn as a standalone entity is closer to the high-$20's per share. He reiterates a Neutral rating on Akorn with a $34 price target, reflecting the proposed deal price.
10/13/17
WELS
10/13/17
NO CHANGE
Target $276
WELS
Outperform
Allergan settlement leaves three Restasis challengers, say Wells Fargo
Wells Fargo analyst David Maris says three Restasis generic challengers remain after Allergan (AGN) reached a settlement with InnoPharma. The settlement, which allows InnoPharma to launch a generic Restasis in the U.S. beginning February 24, 2024, or six months before the expiration of Allergan's patents, points to the complexity of Restasis and the difficulty of getting a generic version approved, Maris tells investors in a research note. InnoPharma was one of four included in a consolidated lawsuit against Allergan, with Teva (TEVA), Mylan (MYL) and Akorn (AKRX) remaining, Maris points out. He's encouraged that the settlement date reached with InnoPharma is close to the expiration date of the patents. The analyst keeps an Outperform rating on Allergan with a $276 price target.
10/16/17
WELS
10/16/17
NO CHANGE
WELS
Outperform
Court ruling looks 'clearly negative' for Allergan, says Wells Fargo
Wells Fargo analyst David Maris says a federal judge ruling today that Allergan's (AGN) Restasis patents are invalid "appears clearly negative" for the company. Due to the magnitude of the potential damages involved, however, an at-risk generic launch is unlikely, Maris tells investors in an intraday research note. As such, the analyst continues to believe the earliest that a generic version of Restasis may enter the market is sometime in 2019. Maris keeps an Outperform rating on Allergan. He adds that today's court ruling is incrementally positive for generic Restasis filers, if approved, including Teva (TEVA), Mylan ( MYL) and Akorn (AKRN).
FSNUY Fresenius SE
$19.91

0.505 (2.60%)

04/25/17
PIPR
04/25/17
DOWNGRADE
Target $34
PIPR
Neutral
Akorn downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst David Amsellem downgraded Akorn (AKRX) to Neutral citing the takeover by Fresenius SE (FSNUY). The analyst believes the transaction price is reasonable and does not expect another suitor coming in at a dramatically higher price point. He raised his price target for Akorn shares to $34 from $29.
04/25/17
CHLM
04/25/17
DOWNGRADE
Target $34
CHLM
Hold
Akorn downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Matt Hewitt downgraded Akorn (AKRX) to Hold from Buy, with a $34 price target, after the announcement that it has agreed to sell the company to Fresenius (FSNUY) for $34 per share in cash and the assumption of about $450M in debt. While the analyst would have liked to have seen Akorn sell for more, the deal still creates "significant value" for many shareholders and is a strategically complementary marriage that makes sense for both sides.
11/17/17
UBSW
11/17/17
DOWNGRADE
UBSW
Sell
Fresenius SE downgraded to Sell from Neutral at UBS
UBS analyst Ian Douglas-Pennant downgraded Fresenius SE to Sell saying he expects pricing pressure to spread to injectables. The rate of injectable generic drug approvals in the U.S. has increased 40% over the past year years, and those to compete against Fresenius' Kabi more than tripled, the analyst contends. He cut his price target for the shares to EUR 57 from EUR 74.

TODAY'S FREE FLY STORIES

01:55
12/14/18
12/14
01:55
12/14/18
01:55
General news
Asian Market Wrap: »

Asian Market Wrap:…

LVMHY

Lvmh ADR

$0.00

(0.00%)

, BEL

Belmond

$17.67

-0.3 (-1.67%)

19:07
12/13/18
12/13
19:07
12/13/18
19:07
Periodicals
LVMH near deal to acquire Belmond for $25 per share in cash, WSJ says »

LVMH (LVMHY) is near a…

LVMHY

Lvmh ADR

$0.00

(0.00%)

BEL

Belmond

$17.67

-0.3 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$175.87

-0.88 (-0.50%)

, JPM

JPMorgan

$101.08

0.03 (0.03%)

19:03
12/13/18
12/13
19:03
12/13/18
19:03
Periodicals
Goldman, JPMorgan, Citi invest in startup AccessFintech, Reuters says »

Goldman Sachs (GS),…

GS

Goldman Sachs

$175.87

-0.88 (-0.50%)

JPM

JPMorgan

$101.08

0.03 (0.03%)

C

Citi

$55.77

-0.22 (-0.39%)

CS

Credit Suisse

$11.26

-0.07 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 26

    Feb

  • 15

    Apr

  • 13

    Jul

TIK

Tel-Instrument

$3.05

(0.00%)

, SGMS

Scientific Games

$15.77

-1.31 (-7.67%)

18:45
12/13/18
12/13
18:45
12/13/18
18:45
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Tel-Instrument…

TIK

Tel-Instrument

$3.05

(0.00%)

SGMS

Scientific Games

$15.77

-1.31 (-7.67%)

XPO

XPO Logistics

$44.33

-15.92 (-26.42%)

COST

Costco

$226.41

-1.41 (-0.62%)

ADBE

Adobe

$247.71

2.27 (0.92%)

YECO

Yulong Eco-Materials

$5.00

0.42 (9.17%)

SBUX

Starbucks

$66.90

0.8 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

NXST

Nexstar

$85.78

-1.98 (-2.26%)

, SBGI

Sinclair Broadcast

$28.74

-1.2 (-4.01%)

18:31
12/13/18
12/13
18:31
12/13/18
18:31
Hot Stocks
DOJ reaches settlement with Nexstar »

The Department of Justice…

NXST

Nexstar

$85.78

-1.98 (-2.26%)

SBGI

Sinclair Broadcast

$28.74

-1.2 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$4.79

-0.11 (-2.24%)

18:18
12/13/18
12/13
18:18
12/13/18
18:18
Hot Stocks
Hudbay Minerals says Waterton has withdrawn its special meeting requisition »

Hudbay Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FB

Facebook

$145.07

0.81 (0.56%)

, T

AT&T

$29.91

-0.26 (-0.86%)

18:17
12/13/18
12/13
18:17
12/13/18
18:17
Periodicals
Facebook seeks to sell cable TV subscriptions, Recode says »

Facebook (FB) is seeking…

FB

Facebook

$145.07

0.81 (0.56%)

T

AT&T

$29.91

-0.26 (-0.86%)

CBS

CBS

$47.90

-0.76 (-1.56%)

LGF.A

Lionsgate

$15.75

-0.87 (-5.23%)

LGF.B

Lionsgate

$14.60

-0.635 (-4.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

  • 30

    Jan

  • 20

    Mar

QCOM

Qualcomm

$58.09

0.36 (0.62%)

, AAPL

Apple

$170.93

1.84 (1.09%)

18:12
12/13/18
12/13
18:12
12/13/18
18:12
Periodicals
Judge says evidence of Apple switch can't be used in Qualcomm case, Reuters says »

A federal judge…

QCOM

Qualcomm

$58.09

0.36 (0.62%)

AAPL

Apple

$170.93

1.84 (1.09%)

INTC

Intel

$48.29

0.46 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

XPO

XPO Logistics

$44.33

-15.92 (-26.42%)

18:10
12/13/18
12/13
18:10
12/13/18
18:10
Hot Stocks
XPO Logistics says report from short selling firm 'intentionally misleading' »

XPO Logistics issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQNR

Equinor

$22.97

0.08 (0.35%)

18:08
12/13/18
12/13
18:08
12/13/18
18:08
Downgrade
Equinor rating change at Goldman Sachs »

Equinor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQNR

Equinor

$22.97

0.08 (0.35%)

18:03
12/13/18
12/13
18:03
12/13/18
18:03
Downgrade
Equinor rating change at Goldman Sachs »

Equinor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$170.93

1.84 (1.09%)

18:01
12/13/18
12/13
18:01
12/13/18
18:01
Periodicals
Apple Connect to shut down in 2019, Apple Insider says »

According to a report out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOB

Live Oak Bancshares

$15.19

0.09 (0.60%)

17:58
12/13/18
12/13
17:58
12/13/18
17:58
Hot Stocks
Live Oak Bancshares President Neil Lawrence Underwood buys 15,546 shares »

Live Oak Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.90

0.8 (1.21%)

17:55
12/13/18
12/13
17:55
12/13/18
17:55
Hot Stocks
Starbucks slips after cutting long-term EPS target »

Shares of Starbucks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

AAPL

Apple

$170.93

1.84 (1.09%)

17:53
12/13/18
12/13
17:53
12/13/18
17:53
Periodicals
Apple Connect to shut down in 2019 »

According to a report out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HESM

Hess Midstream Partners

$19.93

0.5 (2.57%)

17:53
12/13/18
12/13
17:53
12/13/18
17:53
Recommendations
Hess Midstream Partners analyst commentary at MUFG »

Hess Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$247.71

2.27 (0.92%)

17:46
12/13/18
12/13
17:46
12/13/18
17:46
Hot Stocks
Adobe says adding Marketo immediately adds revenue growth »

Says entire document…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AES

AES Corp.

$15.78

-0.11 (-0.69%)

17:45
12/13/18
12/13
17:45
12/13/18
17:45
Conference/Events
AES Corp. management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MTN

Vail Resorts

$221.16

-3.77 (-1.68%)

17:42
12/13/18
12/13
17:42
12/13/18
17:42
Hot Stocks
Vail Resorts director John Sorte sells over $500,000 in company shares »

Vail Resorts director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YECO

Yulong Eco-Materials

$5.00

0.42 (9.17%)

17:42
12/13/18
12/13
17:42
12/13/18
17:42
Hot Stocks
Yulong Eco-Materials delisting from Nasdaq »

Yulong Eco-Materials has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLP

One Liberty Properties

$26.17

-0.09 (-0.34%)

17:42
12/13/18
12/13
17:42
12/13/18
17:42
Hot Stocks
One Liberty Properties acquires industrial property in Missouri for $10M »

One Liberty Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$11.58

-1.18 (-9.25%)

17:38
12/13/18
12/13
17:38
12/13/18
17:38
Hot Stocks
United Natural Foods Chairman Steven Spinner buys 18,000 shares »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EME

Emcor

$64.78

-1.07 (-1.62%)

17:37
12/13/18
12/13
17:37
12/13/18
17:37
Initiation
Emcor initiated at Maxim »

Emcor initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CECE

CECO Environmental

$7.54

-0.14 (-1.82%)

17:36
12/13/18
12/13
17:36
12/13/18
17:36
Initiation
CECO Environmental initiated at Maxim »

CECO Environmental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

CPA

Copa Holdings

$77.37

-2.55 (-3.19%)

17:34
12/13/18
12/13
17:34
12/13/18
17:34
Hot Stocks
Copa Holdings reports November traffic up 6.7% »

Copa Holdings released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.